bpc-157 gut healing evidence Frontiers bpc-157 gut healing research and

For instance, the intranasal delivery of SA55, a broad-spectrum anti-SARS-CoV-2 monoclonal antibody (mAb), has been evaluated in a Phase I clinical trial for safety and tolerability in healthy volunteers (Hu et al., 2024)

Stability: BPC-157 is unusually stable for a peptide: it resists degradation in human gastric juice for 24+ hours, a property that underpins its oral bioavailability

Do not use this guide as a substitute for professional medical evaluation

They send instructions to cells

It effectively counteracts the inherent ulcerogenic potential of various NSAIDs and provides protection even in conditions of ethanol stomach lesions, somatosensory neurons depletion, short bowel, and NOS-blockade